A fourth dose of Pfizer-BioNTech’s vaccine was insufficient to prevent infection
#1

A fourth dose of Pfizer-BioNTech’s vaccine was insufficient to prevent infection against omicron, according to preliminary trial data from Israel. https://bloom.bg/3IhPspl
Reply
#2

Then move on to the 5th lor.
Reply
#3

how about combining 5tg and 6th? sure sufficient
Reply
#4

more variant in the making. Rotfl 
then the west can sell more 'koyok' to the world
Reply
#5

(18-01-2022, 08:52 PM)WhatDoYouThink? Wrote:  how about combining 5tg and 6th? sure sufficient

But when will these jabs end. or is it open-ended vaccination.....
Reply
#6

They dun realise the more doses they have the variant has learned n adapted to go around d vaccine?

There is no right or wrong decisions. 
One only has to bear the consequences that one makes  Big Grin
Reply
#7

Don't worry one can use the Pfizer pills in the meantime.

Paxlovid is meant to be taken as 30 pills over five days. About USD530 per person.

Once the Omicron-specific vaccine is out in March or June, one can then go for it again.
Reply
#8

(18-01-2022, 09:32 PM)theold Wrote:  Don't worry one can use the Pfizer pills in the meantime.

Paxlovid is meant to be taken as 30 pills over five days.

Has these pills been approved by MOH.......?
Reply
#9

Singapore also tried experimental drugs for patients.
Reply
#10

After two Pfizer, can wait how long maximum then do booster to remain vaccinated status?
Reply
#11

(18-01-2022, 09:32 PM)theold Wrote:  Don't worry one can use the Pfizer pills in the meantime.

Paxlovid is meant to be taken as 30 pills over five days. About USD530 per person.

Once the Omicron-specific vaccine is out in March or June, one can then go for it again.

Omicron is decade differences with older circulation variants,
thus specific would be better.
 
But in the first place jab vaccine cannot prevent infection
as it produce antibodies in the blood vessels and organ
not the main entry points, nose and lung side.
Reply


Forum Jump:


Users browsing this thread: 1 Guest(s)